Schonfeld Strategic Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-105,280
| Closed | -$3.14M | – | 2261 |
|
|
2024
Q4 | $3.14M | Buy |
+105,280
| New | +$3.14M | 0.02% | 617 |
|
|
2024
Q3 | – | Sell |
-101,140
| Closed | -$1.73M | – | 2115 |
|
|
2024
Q2 | $1.73M | Sell |
101,140
-262,637
| -72% | -$4.5M | 0.01% | 855 |
|
|
2024
Q1 | $5.69M | Buy |
363,777
+287,014
| +374% | +$4.49M | 0.04% | 504 |
|
|
2023
Q4 | $1.15M | Buy |
76,763
+28,113
| +58% | +$420K | 0.01% | 916 |
|
|
2023
Q3 | $786K | Buy |
+48,650
| New | +$786K | 0.01% | 971 |
|
|
2023
Q1 | – | Sell |
-342
| Closed | -$25.1K | – | 2367 |
|
|
2022
Q4 | $25.1K | Buy |
+342
| New | +$25.1K | ﹤0.01% | 2252 |
|
|
2022
Q2 | – | Sell |
-11,300
| Closed | -$936K | – | 2754 |
|
|
2022
Q1 | $936K | Buy |
+11,300
| New | +$936K | 0.01% | 971 |
|
|
2021
Q4 | – | Sell |
-1,812
| Closed | -$211K | – | 2227 |
|
|
2021
Q3 | $211K | Buy |
+1,812
| New | +$211K | ﹤0.01% | 1656 |
|
|
2020
Q4 | – | Sell |
-5,296
| Closed | -$589K | – | 1726 |
|
|
2020
Q3 | $589K | Buy |
+5,296
| New | +$589K | 0.01% | 825 |
|
|
2020
Q2 | – | Sell |
-14,674
| Closed | -$988K | – | 1419 |
|
|
2020
Q1 | $988K | Buy |
+14,674
| New | +$988K | 0.06% | 374 |
|
|
2019
Q4 | – | Sell |
-15,097
| Closed | -$1.13M | – | 1395 |
|
|
2019
Q3 | $1.13M | Buy |
+15,097
| New | +$1.13M | 0.03% | 445 |
|